Publications

Eribulin for patients with metastatic breast cancer in England 2012-2021: Survival outcomes and 30-day mortality.

Wang Z. et al, (2026), Breast, 89

Evaluating breast cancer surgery ascertainment in England's routine healthcare data: A retrospective cohort study.

Wang L. et al, (2026), Cancer Epidemiol, 104

Clinicopathological, multimodal treatment, and survival patterns for men with breast cancer in England and Wales: a population-based cohort study.

Boyle JM. et al, (2026), EClinicalMedicine, 97

Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023).

Perletta V. et al, (2026), ESMO Real World Data Digit Oncol, 12

Age, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data.

Blacker S. et al, (2026), BMJ Open, 16

Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Electronic address: bc.overview@ndph.ox.ac.uk . and Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ., (2026), Lancet, 407, 1699 - 1711

The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report.

Hanbury G. et al, (2026), Clin Oncol (R Coll Radiol), 52

Reducing locoregional treatments in low risk early invasive breast cancer.

Potter S. et al, (2026), Eur J Surg Oncol, 52

Impact of sex on chemotherapy toxicity and efficacy in biliary tract cancer: Analysis of ABC, BILCAP trials and population data.

Wagner AD. et al, (2026), JHEP Rep, 8

Evaluation of methods to classify ipsilateral breast tumour recurrences as local recurrence or new primary tumour.

Blacker S. et al, (2026), NPJ Breast Cancer

The development and validation of a risk score : LUng Cancer Improved Decisions (LUCID).

Almossawi O. et al, (2026), Int J Popul Data Sci, 11

Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-Analysis.

Kazmi F. et al, (2025), Clin Oncol (R Coll Radiol), 48

Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective.

Hannoun-Levi J-M. et al, (2025), Eur J Surg Oncol, 51

The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus.

Pfob A. et al, (2025), Lancet Oncol, 26, e694 - e706

The impact of radiotherapy on trials of axillary management in early breast cancer.

Oliveros S. et al, (2025), Radiother Oncol, 212

Cookies on this website

Search results (296)